Department of Epidemiology, Columbia University Mailman School of Public Health, New York, New York, USA.
Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Subst Use Misuse. 2024;59(8):1210-1220. doi: 10.1080/10826084.2024.2330906. Epub 2024 Mar 22.
People with a history of injection drug use face discrimination in healthcare settings that may impede their use of routine care, leading to greater reliance on the emergency department (ED) for addressing health concerns. The relationship between discrimination in healthcare settings and subsequent ED utilization has not been established in this population.
This analysis used longitudinal data collected between January 2014 and March 2020 from participants of the ALIVE (AIDS Linked to the IntraVenous Experience) study, a community-based observational cohort study of people with a history of injection drug use in Baltimore, Maryland. Logistic regressions with generalized estimating equations were used to estimate associations between drug use-related discrimination in healthcare settings and subsequent ED utilization for the sample overall and six subgroups based on race, sex, and HIV status.
1,342 participants contributed data from 7,289 semiannual study visits. Participants were predominately Black (82%), mostly male (66%), and 33% were living with HIV. Drug use-related discrimination in healthcare settings (reported at 6% of study visits) was positively associated with any subsequent ED use (OR = 1.40, 95% CI: 1.15-1.72). Positive associations persisted after adjusting for covariates, including past sixth-month ED use and drug use, among the overall sample (aOR = 1.28, 95% CI: 1.04-1.59) and among some subgroups.
Drug use-related discrimination in healthcare settings was associated with greater subsequent ED utilization in this sample. Further exploration of mechanisms driving this relationship may help improve care and optimize healthcare engagement for people with a history of injection drug use.
有注射毒品史的人在医疗保健环境中面临歧视,这可能阻碍他们使用常规护理,导致更多地依赖急诊部门(ED)来解决健康问题。在这一人群中,医疗保健环境中的歧视与随后的 ED 使用之间的关系尚未确定。
本分析使用了 2014 年 1 月至 2020 年 3 月期间从巴尔的摩马里兰州的注射毒品史人群的基于社区的观察性队列研究 ALIVE(AIDS Linked to the IntraVenous Experience)研究参与者中收集的纵向数据。使用广义估计方程的逻辑回归来估计医疗保健环境中与药物使用相关的歧视与总体样本以及基于种族、性别和 HIV 状况的六个亚组随后的 ED 使用之间的关联。
1342 名参与者提供了来自 7289 次半年度研究访问的数据。参与者主要为黑人(82%),大多数为男性(66%),33%的人携带 HIV。医疗保健环境中与药物使用相关的歧视(在 6%的研究访问中报告)与任何随后的 ED 使用呈正相关(OR=1.40,95%CI:1.15-1.72)。在调整了包括过去六个月 ED 使用和药物使用在内的协变量后,总体样本(aOR=1.28,95%CI:1.04-1.59)和一些亚组中,这种关联仍然存在。
在本样本中,医疗保健环境中与药物使用相关的歧视与随后的 ED 使用增加有关。进一步探讨驱动这种关系的机制可能有助于改善对有注射毒品史的人的护理,并优化他们对医疗保健的参与。